CELEX: 62015TB0235(01)
Language: en
Date: 2016-05-23 00:00:00
Title: Case T-235/15 R: Order of the President of the General Court of 23 May 2016 — Pari Pharma v EMA (Application for interim measures — Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market — Order granting suspension of operation of the decision to grant a third party access to the documents — Application for cancellation — No change in circumstances — Article 159 of the Rules of Procedure of the General Court)

18.7.2016   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 260/39
            
         Order of the President of the General Court of 23 May 2016 — Pari Pharma v EMA
   (Case T-235/15 R)
   ((Application for interim measures - Access to documents - Regulation (EC) No 1049/2001 - Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market - Order granting suspension of operation of the decision to grant a third party access to the documents - Application for cancellation - No change in circumstances - Article 159 of the Rules of Procedure of the General Court))
   (2016/C 260/49)
   Language of the case: English
   
      Parties
   
   
      Applicant: Pari Pharma GmbH (Starnberg, Germany) (represented by: M. Epping and W. Rehmann, lawyers)
   
      Defendant: European Medicines Agency (represented by: T. Jabłoński, N. Rampal Olmedo, A. Spina, A. Rusanov and S. Marino, acting as Agents)
   
      Intervener in support of the defendant: Novartis Europharm Ltd (Camberley, United Kingdom) (represented by: C. Schoonderbeek, lawyer)
   
      Re:
   
   Application based on Article 159 of the Rules of Procedure of the General Court seeking the cancellation of the order of 1 September 2015 in Pari Pharma v EMA (T-235/15 R, EU:T:2015:587), by which it granted the suspension of operation of Decision EMA/271043/2015 of the EMA of 24 April 2015, granting to a third party, pursuant to Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to certain documents containing information submitted in the context of an application for marketing authorisation for the medicinal product Vantobra.
   
      Operative part of the order
   
   
               1.
            
            
               The request seeking the cancellation of the order of 1 September 2015 in Pari Pharma v EMA (T-235/15 R, EU:T:2015:587) is rejected.
            
         
               2.
            
            
               The costs are reserved.